Panzyga 100 mg/mL
immune globulin intravenous (human) · SOLUTION · Pfizer Laboratories Div Pfizer Inc
Panzyga is an intravenous immune globulin solution made from human antibodies that is used to treat certain immune system disorders and conditions where the body cannot produce enough antibodies on its own. It works by providing antibodies to help fight infections and reduce inflammation in patients with immunodeficiency conditions.
Key Facts
- Brand Name
- Panzyga
- Generic Name
- immune globulin intravenous (human)
- NDC Code (Product)
0069-1011- Manufacturer
- Pfizer Laboratories Div Pfizer Inc
- Strength
- 100 mg/mL
- Dosage Form
- SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA125587
- Marketing Start
- 08/09/2019
Recall History
No Recall HistoryFull Prescribing Information
Indications & Usage
Category V For the temporary relief of general cold and flu symptoms, fever, achiness, and cough.
Dosage & Administration
Category V Orally 25 drops, 2 times per day or as directed by a physician. Children 12 and under use one half the adult dosage.
Warnings
Category V Use only under the direction of a health care professional. Do not use if tamper evident seal is broken or missing.
Frequently Asked Questions
What is Panzyga used for?
Panzyga is an intravenous immune globulin solution made from human antibodies that is used to treat certain immune system disorders and conditions where the body cannot produce enough antibodies on its own. It works by providing antibodies to help fight infections and reduce inflammation in patients with immunodeficiency conditions.
Is Panzyga a controlled substance?
Panzyga is not classified as a controlled substance by the DEA.
What is the generic name for Panzyga?
The generic name for Panzyga is immune globulin intravenous (human). There are 4 other brand versions of immune globulin intravenous (human).
What is the NDC code for Panzyga 100 mg/mL?
The NDC (National Drug Code) for Panzyga 100 mg/mL is 0069-1011, listed by Pfizer Laboratories Div Pfizer Inc.